Exploring new bioprocess considerations for cardiomyogenesis of embryonic stem cells
Ex vivo cardiomyocytes production from pluripotent stem cells is highly attractive as a future clinical therapy for cardiovascular diseases. Scaled-up 3-dimensional cell culture can be used to produce clinically relevant cell numbers but requires numerous bioprocess design considerations. In this th...
Main Author: | |
---|---|
Other Authors: | |
Published: |
Imperial College London
2013
|
Subjects: | |
Online Access: | http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.656538 |